Cellectis (CLLS) Inventory Average (2017 - 2021)
Cellectis (CLLS) posted quarterly Inventory Average of $2.1 million for Q3 2021, down 65.4% year-over-year from $6.0 million in Q3 2020, and down 46.78% quarter-over-quarter from $3.9 million in Q2 2021.
Analysis
Cellectis (CLLS) Inventory Average (2017 - 2021) Analysis & Trends
Cellectis' Inventory Average history runs 5 years deep, the most recent figure standing at $2.1 million for Q3 2021.
- In Q3 2021, Inventory Average fell 65.4% year-over-year to $2.1 million; the TTM figure through Sep 2021 stood at $2.1 million (down 65.4% YoY), while the FY2020 annual figure was $2.2 million, up 41.77% from the prior year.
- Inventory Average for Q3 2021 stood at $2.1 million, down from $3.9 million in the prior quarter.
- The five-year high for Inventory Average was $6.0 million in Q3 2020, with the low at $116931.1 in Q1 2017.
- The 5-year median for Inventory Average is $1.0 million (2019), against an average of $1.9 million.
- The sharpest annual moves came in 2019 and 2021: Inventory Average soared 1153.21% in 2019, then sank 65.4% in 2021.
- Cellectis' Inventory Average stood at $187500.0 in 2017, then jumped by 32.8% to $249000.0 in 2018, then jumped by 1153.21% to $3.1 million in 2019, then increased by 25.97% to $3.9 million in 2020, then tumbled by 47.32% to $2.1 million in 2021.
- Business Quant data shows CLLS's Inventory Average at $2.1 million in Q3 2021, $3.9 million in Q2 2021, and $3.5 million in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 2.07 Mn |
| Jun 30, 2021 | 3.89 Mn |
| Mar 31, 2021 | 3.46 Mn |
| Dec 31, 2020 | 3.93 Mn |
| Sep 30, 2020 | 5.99 Mn |
| Jun 30, 2020 | 4.65 Mn |
| Mar 31, 2020 | 3.24 Mn |
| Dec 31, 2019 | 3.12 Mn |
| Sep 30, 2019 | 2.17 Mn |
| Jun 30, 2019 | 1.02 Mn |
| Mar 31, 2019 | 664,500.00 |
| Dec 31, 2018 | 249,000.00 |
| Sep 30, 2018 | 227,000.00 |
| Jun 30, 2018 | 217,000.00 |
| Mar 31, 2018 | 226,500.00 |
| Dec 31, 2017 | 187,500.00 |
| Sep 30, 2017 | 125,174.31 |
| Jun 30, 2017 | 119,140.88 |
| Mar 31, 2017 | 116,931.12 |